Showing 141 - 150 of 152
Persistent link: https://www.econbiz.de/10010152478
Persistent link: https://www.econbiz.de/10013029405
Persistent link: https://www.econbiz.de/10013018935
The purpose of this paper is to provide an account of the full set of possible means by which value based pricing (VBP) might be operationalised; to describe and categorise them by developing a taxonomy of approaches; to give an initial assessment of the challenges, pros and cons that each of the...
Persistent link: https://www.econbiz.de/10013018949
Background: The UK Government is proposing to include “burden of illness” in its proposed scheme for the value‐based pricing (VBP) of branded medicines. The VBP consultation document suggests that medicines that tackle diseases associated with high levels of burden of illness will be...
Persistent link: https://www.econbiz.de/10013019102
Objectives: In light of the apparent disconnect between traditional measures of societal well-being such as GDP and reported levels of happiness, governments globally are turning their attention to alternative subjective measures of well-being (SWB) to aid policy decisions. In the context of...
Persistent link: https://www.econbiz.de/10013019286
Objectives: The objectives of this research were to identify the cost-effectiveness of health care services at the margin in the Scottish NHS; consider the extent to which the thresholds observed in Scottish NHS decision making are consistent with the threshold being used to make judgements...
Persistent link: https://www.econbiz.de/10013019353
Persistent link: https://www.econbiz.de/10012615272
Background: The UK Government is proposing to include “burden of illness” in its proposed scheme for the value-based pricing (VBP) of branded medicines. The VBP consultation document suggests that medicines that tackle diseases associated with high levels of burden of illness will be...
Persistent link: https://www.econbiz.de/10014159177
This paper examines the effect different specifications of the Time Tradeoff (TTO) task have on health state values. The new lead time TTO is compared to a method called lag time TTO, both in two time frames. We test whether the two methods yield comparable health state values and whether the...
Persistent link: https://www.econbiz.de/10014170774